跳至主要内容
临床试验/NCT02609724
NCT02609724已完成不适用

Effectiveness of Fluoroscopy-guided Manual Lymph Drainage (MLD) Versus Traditional MLD or Placebo MLD, as Part of Decongestive Lymphatic Therapy, for the Treatment of Breast Cancer-related Lymphoedema (BCRL): a Randomised Controlled Trial

Universitaire Ziekenhuizen KU Leuven3 个研究点 分布在 1 个国家目标入组 194 人开始时间: 2016年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
194
试验地点
3
主要终点
Lymphoedema Volume at the Level of the Arm/ Hand

研究概览

简要总结

The main scientific objective of this multicentric double-blinded randomised controlled trial entails examining the effectiveness of fluoroscopy-guided MLD versus traditional MLD versus placebo MLD, applied as part of the intensive and maintenance phase of Decongestive Lymphatic Therapy, for the treatment of BCRL Secondary scientific objectives entail examining the relationship between different variables of lymphoedema at baseline

详细描述

According to the International Society of Lymphology, lymphoedema needs to be treated with Decongestive Lymphatic Therapy (Consensus Document ISL 2013). This is a two-stage treatment programme. During the first or intensive phase, lymphoedema has to be maximally reduced. This phase consists of skin care, manual lymph drainage (MLD), multi-layer bandaging and exercise therapy. The second or maintenance phase aims to conserve and optimise the results obtained in the first phase. It consists of skin care, compression by a low-stretch elastic sleeve, exercises and lymph drainage. Skin care, multi-layer bandaging, elastic sleeve and exercises are treatment modalities that (after instructing the patient) can be performed by the patient herself. MLD has to be applied by a physical therapist and hence entails a big financial cost for the patient and the Health Care (Kärki et al 2009). The effectiveness of MLD applied during the intensive phase has been investigated by 5 randomised controlled trials, but there is conflicting evidence. So, further investigation is warranted to determine the relative benefit of MLD. The effectiveness of MLD applied during the maintenance phase has never been investigated (Devoogdt et al 2010, Oremus et al 2012, Huang et al 2013, Ezzo et al 2015).

A possible explanation why MLD is not obviously proven to be effective, is that MLD is applied in an inefficient way: during MLD, hand manoeuvres are applied on all lymph nodes and lymphatics that may be anatomically present. After axillary dissection and/ or radiotherapy (for the treatment of breast cancer), the lymphatic system is damaged: lymph nodes are removed and often fibrosis of the superficial lymphatic system occurs. As a result, rerouting of the lymphatic drainage occurs. Rerouting is patient-specific, consequently, it is possible that the traditional MLD needs be abandoned and a tailored approach needs to be established. Lymphofluoroscopy can aid to apply a more efficient MLD. During lymphofluoroscopy, a fluorescent substance is injected subcutaneously in the hand and it visualizes the transport of lymph from the hand up to the axilla and it demonstrates alternative pathways towards other lymph nodes.

A second explanation why the traditional method of MLD is not proven to be effective, is that research has shown that MLD with high pressure (vs low pressure) is more effective to improve lymph transport, as well as gliding (vs no gliding). During the new method of MLD (or fluoroscopy-guided MLD), the therapist only performs hand movements on functional lymphatics and lymph nodes. In addition, the hand movements are applied with higher pressure and lymph transport through the lymph collaterals is stimulated by applying strikes across the skin.

Therefore, the main scientific objective entails examining the effectiveness of fluoroscopy-guided MLD versus traditional MLD versus placebo MLD, applied as part of the intensive and maintenance phase of Decongestive Lymphatic Therapy, for the treatment of BCRL

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age >18y (since the treatment with MLD and the investigation using ICG is not dangerous for pregnant women, women with child bearing age are included)
  • •Women/ men with breast cancer-related lymphoedema
  • •Chronic lymphoedema (>3 months present), stage I to IIb
  • •At least 5% difference between both arms and/ or hands, adjusted for dominance
  • •Written informed consent obtained

排除标准

  • •Allergy for iodine, sodiumiodine, ICG
  • •Increased activity of the thyroid gland; benign tumors of the thyroid gland
  • •Age <18y
  • •Oedema of the upper limb from other causes
  • •Active metastasis of the cancer
  • •Surgery of the lymphatic system in the past (lymph node transplantation, lymphovenous shunt)
  • •Cannot participate during the entire study period
  • •Mentally or physically unable to participate in the study

研究组 & 干预措施

Fluoroscopy-guided MLD

Experimental

Information, skin care, compression therapy, exercises and fluoroscopy-guided MLD 3 weeks (14 sessions of 60 minutes) of intensive treatment 6 months (18 sessions of 60 minutes) of maintenance treatment 6 months of follow-up

干预措施: Information (Other)

Fluoroscopy-guided MLD

Experimental

Information, skin care, compression therapy, exercises and fluoroscopy-guided MLD 3 weeks (14 sessions of 60 minutes) of intensive treatment 6 months (18 sessions of 60 minutes) of maintenance treatment 6 months of follow-up

干预措施: Skin care (Other)

Fluoroscopy-guided MLD

Experimental

Information, skin care, compression therapy, exercises and fluoroscopy-guided MLD 3 weeks (14 sessions of 60 minutes) of intensive treatment 6 months (18 sessions of 60 minutes) of maintenance treatment 6 months of follow-up

干预措施: Compression therapy (Other)

Fluoroscopy-guided MLD

Experimental

Information, skin care, compression therapy, exercises and fluoroscopy-guided MLD 3 weeks (14 sessions of 60 minutes) of intensive treatment 6 months (18 sessions of 60 minutes) of maintenance treatment 6 months of follow-up

干预措施: Fluoroscopy-guided MLD (Other)

Traditional MLD

Active Comparator

Information, skin care, compression therapy, exercises and traditional MLD 3 weeks (14 sessions of 60 minutes) of intensive treatment 6 months (18 sessions of 60 minutes) of maintenance treatment 6 months of follow-up

干预措施: Traditional MLD (Other)

Traditional MLD

Active Comparator

Information, skin care, compression therapy, exercises and traditional MLD 3 weeks (14 sessions of 60 minutes) of intensive treatment 6 months (18 sessions of 60 minutes) of maintenance treatment 6 months of follow-up

干预措施: Information (Other)

Traditional MLD

Active Comparator

Information, skin care, compression therapy, exercises and traditional MLD 3 weeks (14 sessions of 60 minutes) of intensive treatment 6 months (18 sessions of 60 minutes) of maintenance treatment 6 months of follow-up

干预措施: Skin care (Other)

Traditional MLD

Active Comparator

Information, skin care, compression therapy, exercises and traditional MLD 3 weeks (14 sessions of 60 minutes) of intensive treatment 6 months (18 sessions of 60 minutes) of maintenance treatment 6 months of follow-up

干预措施: Compression therapy (Other)

Placebo MLD

Placebo Comparator

Information, skin care, compression therapy, exercises and placebo MLD 3 weeks (14 sessions of 60 minutes) of intensive treatment 6 months (18 sessions of 60 minutes) of maintenance treatment 6 months of follow-up

干预措施: Information (Other)

Placebo MLD

Placebo Comparator

Information, skin care, compression therapy, exercises and placebo MLD 3 weeks (14 sessions of 60 minutes) of intensive treatment 6 months (18 sessions of 60 minutes) of maintenance treatment 6 months of follow-up

干预措施: Skin care (Other)

Placebo MLD

Placebo Comparator

Information, skin care, compression therapy, exercises and placebo MLD 3 weeks (14 sessions of 60 minutes) of intensive treatment 6 months (18 sessions of 60 minutes) of maintenance treatment 6 months of follow-up

干预措施: Compression therapy (Other)

Placebo MLD

Placebo Comparator

Information, skin care, compression therapy, exercises and placebo MLD 3 weeks (14 sessions of 60 minutes) of intensive treatment 6 months (18 sessions of 60 minutes) of maintenance treatment 6 months of follow-up

干预措施: Placebo MLD (Other)

结局指标

主要结局

Lymphoedema Volume at the Level of the Arm/ Hand

时间窗: Primary endpoint = After 3 weeks of intensive treatment

= the ratio at the different time points; The (inter-limb) ratio = Relative excessive lymphoedema volume of the arm/ hand = \[(volume arm + volume hand affected side) / (corrected volume arm + corrected volume hand healthy side)\]; Volume arm is determined by performing circumference measurements and calculating the volume with the formula of the truncated cone; Volume hand is determined by the water displacement method; The volume of the non-dominant hand/arm is on average 3.3% smaller than the dominant hand/arm, therefore is the volume of the arm at the healthy side corrected for hand dominance

Stagnation of Fluid at Level of the Shoulder/ Trunk

时间窗: Primary endpoint = After 3 weeks of intensive treatment

Ratio PWC% at the different time intervals = PWC% affected side / PWC% healthy side Measured with the MoistureMeterD compact at the level of shoulder and trunk where after a mean ratio PWC% is calculated

次要结局

  • Extracellular Fluid in the Upper Limb(After 3 weeks of intensive treatment, 1, 3, 6 months of maintenance treatment and 6 months of follow-up)
  • Thickness of Cutis and Subcutis of Arm and Trunk Measured With Ultrasound(After 3 weeks of intensive treatment and 6 months of maintenance treatment and 6 months of follow-up)
  • Problems in Functioning Related to Development of Breast Cancer-related Lymphoedema(After 3 weeks of intensive treatment, 1, 3, 6 months of maintenance treatment and 6 months of follow-up)
  • Elasticity of Skin and Subcutaneous Tissue of Arm and Trunk Using the SkinFibrometer(After 3 weeks of intensive treatment, 1, 3, 6 months of maintenance treatment and 6 months of follow-up)
  • Quality of Life Score(After 3 weeks of intensive treatment and 1, 3, 6 months of maintenance treatment and 6 months of follow-up)
  • Number of Episodes of Erysipelas(Between baseline and the end of the follow-up phase (12 months))
  • Overall Treatment Satisfaction(Between baseline and the end of the follow-up phase (12 months))
  • Manual Lymphatic Drainage (MLD)-Specific Treatment Satisfaction(Between baseline and the end of the follow-up phase (12 months))
  • Local Tissue Water at the Level of the Arm and Trunk(After 3 weeks of intensive treatment phase, after 1, 3, 6 months of maintenance treatments and after 6 months of follow-up)
  • Thickness of the Cutis and Subcutis of the Arm and Trunk Evaluated by Palpation (Pinch Test)(After 3 weeks of intensive treatment, 1, 3, 6 months of maintenance treatment and 6 months of follow-up)
  • Hardness (Fibrosis) of the Skin at the Level of the Arm and Trunk Evaluated Through Palpation(After 3 weeks of intensive treatment, 1, 3, 6 months of maintenance treatment and 6 months of follow-up)
  • Lymphatic Architecture and Function(After 3 weeks of intensive treatment and 6 months of maintenance treatment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验